Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
Efren Olivares joins mobile app company as Partner and EVP-Pharma
NEW YORK, Feb. 4, 2014 /PRNewswire/ -- tapTrak®, a limited liability company creating microjournal mobile applications, announced that Efren Olivares has joined as a partner and EVP of their new pharma division.
"I am excited about joining the tapTrak team, and bringing the tapTrak MED system to the pharmaceutical industry," said Efren Olivares. "I see plenty of opportunities for mobile health in pharma, and I believe tapTrak MED can be applied in many areas within the industry."
Efren Olivares joins tapTrak with over 22 years of global experience in the pharmaceutical and medical device industries having worked at Pfizer, Lilly, Baxter and Dura Pharmaceuticals. Most recently, he was Pfizer's Head of Customer Intelligence, Europe. Over a long and distinguished career, he launched and grew a wide array of pharmaceutical brands in completely new categories and in over 50 markets worldwide. These brands include Aricept, Viagra, Geodon, Lyrica and Celsentri. Efren has a BS in Economics from the Wharton School, University of Pennsylvania and an MBA from the Marshall School of Business, University of Southern California.
"Efren Olivares is a proven leader and accomplished pharmaceutical executive," said Ming Ooi, founder and CEO of tapTrak. "His capabilities and experience paired with tapTrak's traction for our tapTrak MED enterprise system will allow us to enter the pharmaceutical sector with a significant advantage."
tapTrak MED was launched in 2013 with the goal of bringing microjournaling into the medical industry. The cloud-based enterprise system features an app for patients and a web-based dashboard for clinicians. tapTrak MED seeks to encourage patient compliance and promote positive health outcomes via an easy and simple patient app that sends data back to clinicians for review. tapTrak MED is HIPAA compliant and EMR compatible. tapTrak MED is currently being piloted in New Jersey and New York City.
Lead by Efren Olivares, this new pharma division will expand on current tapTrak efforts by customizing the tapTrak MED system specifically for pharmaceutical applications.
Contact: Ming Ooi
firstname.lastname@example.org, (646) 481-9868
©2012 PR Newswire. All Rights Reserved.